- Title
- The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury
- Creators
- Lorraine YURKEWICZ - CNS, Pfizer Global Research and Development, Groton, Connecticut, United StatesJerry WEAVER - Biostatistics, Pfizer Global Research and Development, Groton, Connecticut, United StatesM. Ross BULLOCK - Department of Neurosurgery, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, United StatesLawrence F MARSHALL - Neurosurgical Services, University of California San Diego Medical Center, San Diego, California, United States
- Publication Details
- Journal of neurotrauma, Vol.22(12), pp.1428-1443
- Publisher
- Liebert; Larchmont, NY
- Academic Unit
- UMMG Dept of Neurological Surgery
- Language
- English
- Resource Type
- Journal article
- PMID
- 16379581
- Record Identifier
- 991031561850102976
Journal article
The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury
Journal of neurotrauma, Vol.22(12), pp.1428-1443
2005
PMID: 16379581
Metrics
25 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.5 Neuroscience
- 1.5.268 Glutamate
- Web Of Science research areas
- Clinical Neurology
- Critical Care Medicine
- Neurosciences
- ESI research areas
- Neuroscience & Behavior
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites